Study of IL-33 levels in lupus patients
Part of Immune system & allergy clinical trials.
This study measures a blood protein called IL-33 in people with lupus, including those with kidney involvement (lupus nephritis), to see if it relates to their symptoms. It may help doctors understand lupus better and find new ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with systemic lupus erythematosus (lupus).
- You do not have any other autoimmune diseases or chronic infections.
- You are not pregnant or breastfeeding.
- You are willing to provide a blood sample and agree to the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a protein called uromodulin in the blood can help doctors tell how lupus nephritis (kidney inflammation caused by lupus) is affecting the kidneys. It compares uromodulin levels in people with lupus nephritis, people with lupus but no kidney problems, people with other kidney diseases, and healthy people.
This study compares blood test results between people with lupus and healthy volunteers. It aims to find blood markers that may help understand lupus better.
This study looks at whether certain substances in the blood, such as uric acid, homocysteine, and interleukin-17, are higher in people with lupus-related kidney disease compared to healthy individuals. It aims to find new ways to monitor or understand the condition better.
This study measures a protein called IL-33 in the blood of people with moderate to severe psoriasis to understand how it relates to the disease. Results may help doctors better understand psoriasis and develop new treatments.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
Hear when a new SLE trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.